Press release – For immediate release – 5:45 pm CEST
Median Technologies to participate in several investor conferences in May and June 2025
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis™, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announced today that the Company will participate in upcoming investor conferences in May and June 2025.
- Forum Midcaps Gilbert Dupont – May 13, 2025 – Paris, France
- TP ICAP Midcap Annual Conference – May 15-16, 2025 – Paris, France
- Portzamparc Mid & Small Caps Conference – June 18-19, 2025 – Paris, France
Please get in touch through the respective conference booking systems, if you would like to request a one-on-one meeting with Median management at these events. Conferences are for institutional investors only.